[1]
|
Dickinson, K.M. and Collaco, J.M. (2021) Cystic Fibrosis. Pediatrics in Review, 42, 55-67.
https://doi.org/10.1542/pir.2019-0212
|
[2]
|
Graeber, S.Y. and Mall, M.A. (2023) The Future of Cystic Fibrosis Treatment: From Disease Mechanisms to Novel Therapeutic Approaches. The Lancet (London, England), 402, 1185-1198.
https://doi.org/10.1016/S0140-6736(23)01608-2
|
[3]
|
Guo, X., Liu, K., Liu, Y., et al. (2018) Clinical and Genetic Characteristics of Cystic Fibrosis in CHINESE Patients: A Systemic Review of Reported Cases. Orphanet Journal of Rare Diseases, 13, Article No. 224.
https://doi.org/10.1186/s13023-018-0968-2
|
[4]
|
Guo, J., Garratt, A. and Hill, A. (2022) Worldwide Rates of Di-agnosis and Effective Treatment for Cystic Fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 21, 456-462.
https://doi.org/10.1016/j.jcf.2022.01.009
|
[5]
|
O’Sullivan, B.P. and Freedman, S.D. (2009) Cystic Fibrosis. The Lancet (London, England), 373, 1891-1904.
https://doi.org/10.1016/S0140-6736(09)60327-5
|
[6]
|
Sanders, D.B. and Fink A.K. (2016) Background and Epi-demiology. Pediatric Clinics of North America, 63, 567-584.
https://doi.org/10.1016/j.pcl.2016.04.001
|
[7]
|
Ni, Q., Chen, X., Zhang, P., et al. (2022) Systematic Estimation of Cystic Fibrosis Prevalence in Chinese and Genetic Spectrum Comparison to Caucasians. Orphanet Journal of Rare Diseases, 17, Article No. 129.
https://doi.org/10.1186/s13023-022-02279-9
|
[8]
|
Clayton, T.A., Lindon, J.C., Cloarec, O., et al. (2006) Pharmaco-Metabonomic Phenotyping and Personalized Drug Treatment. Nature, 440, 1073-1077. https://doi.org/10.1038/nature04648
|
[9]
|
Nicholson, J.K. and Lindon, J.C. (2008) Systems Biology: Metabonomics. Nature, 455, 1054-1056.
https://doi.org/10.1038/4551054a
|
[10]
|
Arakaki, A.K., Skolnick, J. and McDonald, J.F. (2008) Marker Metabolites Can Be Therapeutic Targets as Well. Nature, 456, 443. https://doi.org/10.1038/456443c
|
[11]
|
Stringer, K.A., McKay, R.T., Karnovsky, A., et al. (2016) Metabolomics and Its Application to Acute Lung Diseases. Frontiers in Immunology, 7, Article 44. https://doi.org/10.3389/fimmu.2016.00044
|
[12]
|
Wishart, D.S. (2005) Metabolomics: The Principles and Potential Applications to Transplantation. American Journal of Transplantation, 5, 2814-2820. https://doi.org/10.1111/j.1600-6143.2005.01119.x
|
[13]
|
Wishart, D.S. (2010) Computational Approaches to Metabolomics. Methods in Molecular Biology (Clifton, NJ), 593, 283-313. https://doi.org/10.1007/978-1-60327-194-3_14
|
[14]
|
Pinu, F.R., Beale, D.J., Paten, A.M., et al. (2019) Systems Biology and Multi-Omics Integration: Viewpoints from the Metabolomics Research Community. Metabolites, 9, Article 76. https://doi.org/10.3390/metabo9040076
|
[15]
|
Heckendorf, C., Blum, B.C., Lin, W., et al. (2023) Integration of Metabolomic and Proteomic Data to Uncover Actionable Metabolic Pathways. Methods in Molecular Biology (Clifton, NJ), 2660, 137-148.
https://doi.org/10.1007/978-1-0716-3163-8_10
|
[16]
|
Chetty, A. and Blekhman, R. (2024) Multi-Omic Approaches for Host-Microbiome Data Integration. Gut Microbes, 16, Article 2297860. https://doi.org/10.1080/19490976.2023.2297860
|
[17]
|
Joseloff, E., Sha, W., Bell, S.C., et al. (2014) Serum Metabolomics Indicate Altered Cellular Energy Metabolism in Children with Cystic Fibrosis. Pediatric Pulmonology, 49, 463-472. https://doi.org/10.1002/ppul.22859
|
[18]
|
Esther Jr., C.R., Coakley, R.D., Henderson, A.G., et al. (2015) Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis. Chest, 148, 507-515. https://doi.org/10.1378/chest.14-1800
|
[19]
|
O’Connor, J.B., Mottlowitz, M., Kruk, M.E., et al. (2022) Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children with Cystic Fibrosis. Frontiers in Cel-lular and Infection Microbiology, 12, Article 805170.
https://doi.org/10.3389/fcimb.2022.805170
|
[20]
|
Beckonert, O., Keun, H.C., Ebbels, T.M., et al. (2007) Metabolic Profiling, Metabolomic and Metabonomic Procedures for NMR Spectroscopy of Urine, Plasma, Serum and Tissue Ex-tracts. Nature Protocols, 2, 2692-2703.
https://doi.org/10.1038/nprot.2007.376
|
[21]
|
Griffin, J.L. and Kauppinen, R.A. (2007) Tumour Metabolomics in Animal Models of Human Cancer. Journal of Proteome Research, 6, 498-505. https://doi.org/10.1021/pr060464h
|
[22]
|
Mena-Bravo, A. and Luque de Castro, M.D. (2014) Sweat: A Sample with Limited Present Applications and Promising Future in Metabolomics. Journal of Pharmaceutical and Biomedical Analysis, 90, 139-147.
https://doi.org/10.1016/j.jpba.2013.10.048
|
[23]
|
Serkova, N.J., Standiford, T.J. and Stringer, K.A. (2011) The Emerging Field of Quantitative Blood Metabolomics for Biomarker Discovery in Critical Illnesses. American Journal of Respiratory and Critical Care Medicine, 184, 647-655.
https://doi.org/10.1164/rccm.201103-0474CI
|
[24]
|
Alonso, A., Marsal, S. and Julià A. (2015) Analytical Methods in Untargeted Metabolomics: State of the Art in 2015. Frontiers in Bioengineering and Biotechnology, 3, Article 23. https://doi.org/10.3389/fbioe.2015.00023
|
[25]
|
Sas, K.M., Karnovsky, A., Michailidis, G., et al. (2015) Metabo-lomics and Diabetes: Analytical and Computational Approaches. Diabetes, 64, 718-732. https://doi.org/10.2337/db14-0509
|
[26]
|
More, T., RoyChoudhury, S., Gollapalli, K., et al. (2015) Metabolomics and Its Integration with Systems Biology: PSI 2014 Conference Panel Discussion Report. Journal of Proteomics, 127, 73-79.
https://doi.org/10.1016/j.jprot.2015.04.024
|
[27]
|
Markley, J.L., Brüschweiler, R., Edison, A.S., et al. (2017) The Future of NMR-Based Metabolomics. Current Opinion in Biotechnology, 43, 34-40. https://doi.org/10.1016/j.copbio.2016.08.001
|
[28]
|
Basov, N.V., Rogachev, A.D., Aleshkova, M.A., et al. (2024) Global LC-MS/MS Targeted Metabolomics Using a Combination of HILIC and RP LC Separation Modes on an Organic Monolithic Column Based on 1-Vinyl-1,2,4-Triazole. Talanta, 267, Article 125168. https://doi.org/10.1016/j.talanta.2023.125168
|
[29]
|
Bansal, N., Kumar, M. and Gupta, A. (2024) Richer than Pre-viously Probed: An Application of 1H NMR Reveals One Hundred Metabolites Using Only Fifty Microliter Serum. Biophysical Chemistry, 305, Article 107153.
https://doi.org/10.1016/j.bpc.2023.107153
|
[30]
|
Bjerrum, J.T. (2015) Metabonomics: Analytical Techniques and Associated Chemometrics at a Glance. In: Bjerrum, J., Ed., Methods in Molecular Biology (Clifton, NJ), Vol. 1277, Humana Press, New York, 1-14.
https://doi.org/10.1007/978-1-4939-2377-9_1
|
[31]
|
Zamboni, N., Saghatelian, A. and Patti, G.J. (2015) Defining the Metabolome: Size, Flux, and Regulation. Molecular Cell, 58, 699-706. https://doi.org/10.1016/j.molcel.2015.04.021
|
[32]
|
Yurekten, O., Payne, T., Tejera, N., et al. (2024) MetaboLights: Open Data Repository for Metabolomics. Nucleic Acids Research, 52, D640-D646. https://doi.org/10.1093/nar/gkad1045
|
[33]
|
Wishart, D.S., Kruger, R., Sivakumaran, A., et al. (2024) PathBank 2.0—The Pathway Database for Model Organism Metabolomics. Nucleic Acids Research, 52, D654-D662. https://doi.org/10.1093/nar/gkad1041
|
[34]
|
中华医学会儿科学分会呼吸学组, 中华医学会儿科学分会呼吸学组疑难少见病协作组, 国家呼吸系统疾病临床医学研究中心等. 中国儿童囊性纤维化诊断与治疗专家共识[J]. 中华实用儿科临床杂志, 2022, 37(22): 1681-1687.
|
[35]
|
田欣伦. 中国人囊性纤维化[J]. 中国实用儿科杂志, 2023, 38(3): 204-209.
|
[36]
|
Wisniewski, B.L., Shrestha, C.L., Zhang, S., et al. (2020) Metabolomics Profiling of Tobacco Exposure in Children with Cystic Fibrosis. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 19, 791-800.
https://doi.org/10.1016/j.jcf.2020.05.003
|
[37]
|
Esther Jr., C.R., Muhlebach, M.S., Ehre, C., et al. (2019) Mucus Ac-cumulation in the Lungs Precedes Structural Changes and Infection in Children with Cystic Fibrosis. Science Transla-tional Medicine, 11.
https://doi.org/10.1126/scitranslmed.aav3488
|
[38]
|
Scholte, B.J., Horati, H., Veltman, M., et al. (2019) Oxidative Stress and Abnormal Bioactive Lipids in Early Cystic Fibrosis Lung Disease. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 18, 781-789.
https://doi.org/10.1016/j.jcf.2019.04.011
|
[39]
|
Zemanick, E.T., Sagel, S.D. and Harris, J.K. (2011) The Airway Microbiome in Cystic Fibrosis and Implications for Treatment. Current Opinion in Pediatrics, 23, 319-324. https://doi.org/10.1097/MOP.0b013e32834604f2
|
[40]
|
Elizur, A., Cannon, C.L. and Ferkol, T.W. (2008) Airway Inflammation in Cystic Fibrosis. Chest, 133, 489-495.
https://doi.org/10.1378/chest.07-1631
|
[41]
|
Lepissier, A., Addy, C., Hayes, K., et al. (2022) Inflammation Bi-omarkers in Sputum for Clinical Trials in Cystic Fibrosis: Current Understanding and Gaps in Knowledge. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society, 21, 691-706. https://doi.org/10.1016/j.jcf.2021.10.009
|
[42]
|
Wolak, J.E., Esther Jr., C.R., and O’Connell, T.M. (2009) Metabolomic Analysis of Bronchoalveolar Lavage Fluid from Cystic Fibrosis Patients. Biomarkers: Biochemical Indi-cators of Exposure, Response, and Susceptibility to Chemicals, 14, 55-60. https://doi.org/10.1080/13547500802688194
|
[43]
|
Nichols, D., Chmiel, J. and Berger, M. (2008) Chronic In-flammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling. Clinical Reviews in Allergy & Immunology, 34, 146-162.
https://doi.org/10.1007/s12016-007-8039-9
|
[44]
|
Twomey, K.B., Alston, M., An, S.Q., et al. (2013) Microbiota and Metabolite Profiling Reveal Specific Alterations in Bacterial Community Structure and Environment in the Cystic Fibrosis Airway During Exacerbation. PLOS ONE, 8, e82432. https://doi.org/10.1371/journal.pone.0082432
|
[45]
|
Hu, Y. and Coates, A. (2012) Nonmultiplying Bacteria Are Profoundly Tolerant to Antibiotics. In: Coates, A., Ed., Antibiotic Resistance. Handbook of Experimental Pharmacology, Vol. 211, Springer, Berlin, Heidelberg, 99-119.
https://doi.org/10.1007/978-3-642-28951-4_7
|
[46]
|
Quinn, R.A., Phelan, V.V., Whiteson, K.L., et al. (2016) Mi-crobial, Host and Xenobiotic Diversity in the Cystic Fibrosis Sputum Metabolome. The ISME Journal, 10, 1483-1498. https://doi.org/10.1038/ismej.2015.207
|
[47]
|
Robroeks, C.M., Van Berkel, J.J., Dallinga, J.W., et al. (2010) Metabolomics of Volatile Organic Compounds in Cystic Fibrosis Patients and Controls. Pediatric Research, 68, 75-80. https://doi.org/10.1203/PDR.0b013e3181df4ea0
|
[48]
|
Hahn, A., Whiteson, K., Davis, T.J., et al. (2020) Longitu-dinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study. Frontiers in Cellular and Infection Microbiology, 10, Article 174.
https://doi.org/10.3389/fcimb.2020.00174
|
[49]
|
Bhatt, J.M. (2013) Treatment of Pulmonary Exacerbations in Cystic Fibrosis. European Respiratory Review: An Official Journal of the European Respiratory Society, 22, 205-216. https://doi.org/10.1183/09059180.00006512
|
[50]
|
Laguna, T.A., Reilly, C.S., Williams, C.B., et al. (2015) Metabolomics Analysis Identifies Novel Plasma Biomarkers of Cystic Fibrosis Pulmonary Exacerbation. Pediatric Pulmonology, 50, 869-877. https://doi.org/10.1002/ppul.23225
|
[51]
|
Montuschi, P., Paris, D., Melck, D., et al. (2012) NMR Spectroscopy Metabolomic Profiling of Exhaled Breath Condensate in Patients with Stable and Unstable Cystic Fibrosis. Thorax, 67, 222-228.
https://doi.org/10.1136/thoraxjnl-2011-200072
|
[52]
|
Montuschi, P., Paris, D., Montella, S., et al. (2014) Nuclear Magnetic Resonance-Based Metabolomics Discriminates Primary Ciliary Dyskinesia from Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine, 190, 229-233. https://doi.org/10.1164/rccm.201402-0249LE
|
[53]
|
Zang, X., Monge, M.E., McCarty, N.A., et al. (2017) Feasibility of Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics: A Pilot Study. Journal of Proteome Research, 16, 550-558. https://doi.org/10.1021/acs.jproteome.6b00675
|
[54]
|
Zang, X., Monge, M.E., Gaul, D.A., et al. (2020) Early Detection of Cystic Fibrosis Acute Pulmonary Exacerbations by Exhaled Breath Condensate Metabolomics. Journal of Proteome Research, 19, 144-152.
https://doi.org/10.1021/acs.jproteome.9b00443
|